Distinct endotypes of steroid-resistant asthma characterized by IL-17Ahigh and IFN-γhigh immunophenotypes: Potential benefits of calcitriol

[1]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[2]  M. Nojomi,et al.  The effects of vitamin D supplementation on airway functions in mild to moderate persistent asthma. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[3]  C. Hawrylowicz,et al.  The effects of calcitriol treatment in glucocorticoid-resistant asthma. , 2014, The Journal of allergy and clinical immunology.

[4]  Tonya S. King,et al.  Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. , 2014, JAMA.

[5]  P. Pfeffer,et al.  Immunoregulatory mechanisms of vitamin D relevant to respiratory health and asthma , 2014, Annals of the New York Academy of Sciences.

[6]  P. Woodruff,et al.  Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma. , 2014, The Journal of allergy and clinical immunology.

[7]  Madhu Yadav,et al.  Effect of Vitamin D Supplementation on Moderate to Severe Bronchial Asthma , 2014, The Indian Journal of Pediatrics.

[8]  E. Bleecker,et al.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.

[9]  W. Busse,et al.  Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia. , 2013, The Journal of allergy and clinical immunology.

[10]  J. Bird,et al.  Mepolizumab for Severe Eosinophilic Asthma (DREAM): A Multicentre, Double-Blind, Placebo-Controlled Trial , 2013, Pediatrics.

[11]  C. Hawrylowicz,et al.  Enhanced production of IL-17A in patients with severe asthma is inhibited by 1α,25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion. , 2013, The Journal of allergy and clinical immunology.

[12]  S. Wenzel,et al.  Dupilumab in persistent asthma with elevated eosinophil levels. , 2013, The New England journal of medicine.

[13]  A. Regev,et al.  Dynamic regulatory network controlling Th17 cell differentiation , 2013, Nature.

[14]  Q. Hamid,et al.  Glucocorticoid Receptor-Beta Up-Regulation and Steroid Resistance Induction by IL-17 and IL-23 Cytokine Stimulation in Peripheral Mononuclear Cells , 2012, Journal of Clinical Immunology.

[15]  M. Lester.  Steroid Requirements and Immune Associations With Vitamin D Are Stronger in Children Than Adults With Asthma , 2012, Pediatrics.

[16]  A. Litonjua,et al.  Effect of vitamin D and inhaled corticosteroid treatment on lung function in children. , 2012, American journal of respiratory and critical care medicine.

[17]  S. Mosesova,et al.  Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. , 2011, The Journal of allergy and clinical immunology.

[18]  C. Hawrylowicz,et al.  The role of 1α,25‐dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+and IL‐10+ CD4+ T cells , 2012, European journal of immunology.

[19]  C. Hawrylowicz,et al.  Serum 25-dihydroxyvitamin D levels correlate with CD4(+)Foxp3(+) T-cell numbers in moderate/severe asthma. , 2012, The Journal of allergy and clinical immunology.

[20]  S. Wenzel.  Asthma phenotypes: the evolution from clinical to molecular approaches , 2012, Nature Medicine.

[21]  Lee， Jk,et al.  Lebrikizumab treatment in adults with asthma. , 2011 .

[22]  W. Banya,et al.  Relationship between serum vitamin D, disease severity, and airway remodeling in children with asthma. , 2011, American journal of respiratory and critical care medicine.

[23]  Richard J Martin,et al.  Inhibition of histone deacetylase 2 expression by elevated glucocorticoid receptor beta in steroid-resistant asthma. , 2010, American journal of respiratory and critical care medicine.

[24]  J. Martin,et al.  Induction of glucocorticoid receptor‐β expression in epithelial cells of asthmatic airways by T‐helper type 17 cytokines , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[25]  F. Powrie,et al.  Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells , 2010, Immunity.

[26]  I. Agache,et al.  Increased serum IL-17 is an independent risk factor for severe asthma. , 2010, Respiratory medicine.

[27]  J. Brehm,et al.  Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. , 2010, The Journal of allergy and clinical immunology.

[28]  M. Urashima,et al.  Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. , 2010, The American journal of clinical nutrition.

[29]  E. R. Sutherland,et al.  Vitamin D levels, lung function, and steroid response in adult asthma. , 2010, American journal of respiratory and critical care medicine.

[30]  N. Tubridy,et al.  CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis1 , 2009, The Journal of Immunology.

[31]  E. Matsui,et al.  TH17 Cells Mediate Steroid-Resistant Airway Inflammation and Airway Hyperresponsiveness in Mice , 2009, Pediatrics.

[32]  M. Mura,et al.  1,25-Dihydroxyvitamin D3 and IL-2 Combine to Inhibit T Cell Production of Inflammatory Cytokines and Promote Development of Regulatory T Cells Expressing CTLA-4 and FoxP31 , 2009, The Journal of Immunology.

[33]  A. Litonjua,et al.  Vitamin D, the immune system and asthma , 2009, Expert review of clinical immunology.

[34]  P. Duquette,et al.  Preferential recruitment of interferon‐γ–expressing TH17 cells in multiple sclerosis , 2009, Annals of neurology.

[35]  Barmak Modrek,et al.  T-helper type 2-driven inflammation defines major subphenotypes of asthma. , 2009, American journal of respiratory and critical care medicine.

[36]  C. Lemière,et al.  T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. , 2009, The Journal of allergy and clinical immunology.

[37]  D. Bending,et al.  Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. , 2009, The Journal of clinical investigation.

[38]  P. Stephenson,et al.  Summary of the 2008 BTS/SIGN British Guideline on the management of asthma. , 2009, Primary care respiratory journal : journal of the General Practice Airways Group.

[39]  E. Hickman,et al.  Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function. , 2009, The Journal of clinical investigation.

[40]  I. Adcock,et al.  Steroid resistance in asthma: Mechanisms and treatment options , 2008, Current allergy and asthma reports.

[41]  S. Willsie.  Maternal vitamin D intake during pregnancy and early childhood wheezing , 2008 .

[42]  S. Wenzel,et al.  Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies , 2007, The Lancet.

[43]  D. Curran‐Everett,et al.  IL4Rα Mutations Are Associated with Asthma Exacerbations and Mast Cell/IgE Expression , 2007 .

[44]  A. Litonjua,et al.  Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. , 2007, The American journal of clinical nutrition.

[45]  W. Busse,et al.  IL4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expression. , 2007, American journal of respiratory and critical care medicine.

[46]  P. Hellings,et al.  IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? , 2006, Respiratory research.

[47]  R. Maizels,et al.  IL-4R signaling is required to induce IL-10 for the establishment of T(h)2 dominance. , 2006, International immunology.

[48]  M. Dallman,et al.  Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. , 2005, The Journal of clinical investigation.

[49]  R. Scragg,et al.  Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. , 2005, Chest.

[50]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[51]  C. Hawrylowicz,et al.  Interleukin-10-secreting "regulatory" T cells induced by glucocorticoids and beta2-agonists. , 2005, American journal of respiratory cell and molecular biology.

[52]  W. Pierzchała,et al.  Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. , 2003, Respiratory medicine.

[53]  David F. Richards,et al.  In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines , 2002, The Journal of experimental medicine.

[54]  C. Hawrylowicz,et al.  A defect in corticosteroid-induced IL-10 production in T lymphocytes from corticosteroid-resistant asthmatic patients. , 2002, The Journal of allergy and clinical immunology.

[55]  Q. Hamid,et al.  IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. , 2001, The Journal of allergy and clinical immunology.

[56]  A. Sousa,et al.  Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor β-isoform , 2000 .

[57]  K. J. Macleod,et al.  Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma , 2000, Thorax.

[58]  R. Martin,et al.  Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma , 1995, The Journal of experimental medicine.

[59]  M. Gyetko,et al.  Monocyte 1α‐hydroxylase regulation: induction by inflammatory cytokines and suppression by dexamethasone and uremia toxin , 1993, Journal of leukocyte biology.